Achievement in SingApore of cholesterol targets (A- SACT): Implications of the July 2004 NCEP-ATP III recommendations

被引：0
|
作者：
Ho, KT
Chin, KW
Ng, KS
Deb, B
Alemao, E
Rajagopalan, S
Yin, DD
机构：
[1] Natl Univ Singapore Hosp, Singapore 117548, Singapore
[2] Merck Sharp & Dohme Corp, Singapore, Singapore
[3] Tan Tock Seng Hosp, Singapore, Singapore
[4] Alexandra Hosp, Singapore, Singapore
[5] Merck & Co Inc, Whitehouse Stn, NJ USA
来源：
CIRCULATION | 2005年 / 111卷 / 20期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P226
引用
收藏
页码：E354 / E354
页数：1
相关论文
共 8 条
  • [1] The A-SACT (Achievement in Singapore of Cholesterol Targets) study in patients with coronary heart disease
    Ho K.-T.
    Chin K.-W.
    Ng K.-S.
    Alemao E.
    Rajagopalan S.
    Yin D.
    American Journal of Cardiovascular Drugs, 2006, 6 (6) : 383 - 391
  • [2] The NCEP-ATP III recommendations result in undertreatment of the lipid abnormalities of patients with impaired fasting glucose
    Aguilar-Salinas, CA
    Rojas, R
    Gomez-Perez, FJ
    Franco, A
    Riostorres, JM
    Valles, V
    Olaiz, G
    Rull, JA
    DIABETES, 2002, 51 : A150 - A150
  • [3] Stroke patients have cholesterol level's greater than recommended by NCEP-ATP III guidelines
    不详
    FUTURE LIPIDOLOGY, 2007, 2 (02): : 124 - 124
  • [4] Testing national cholesterol education program-adult treatment panel III (NCEP-ATP III) guidelines for central obesity in African Americans
    Sen, Salbyasachi
    Chow, Carson C.
    Ricks, Madia
    Sebring, Nancy G.
    Frempong, Barbara A.
    Sumner, Anne E.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E113 - E114
  • [5] 2013 ACC/AHA Cholesterol Guideline Versus 2004 NCEP ATP III Guideline in the Prediction of Coronary Artery Calcification Progression in a Korean Population
    Cho, Yun Kyung
    Jung, Chang Hee
    Kang, Yu Mi
    Hwang, Jenie Yoonoo
    Kim, Eun Hee
    Yang, Dong Hyun
    Kang, Joon-Won
    Park, Joong-Yeol
    Kim, Hong-Kyu
    Lee, Woo Je
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (08):
  • [6] Measuring effective reductions in cholesterol using rosuvastatin therapy (mercury I): Achievement of LDL-C goals with updated ATP III recommendations
    Schuster, H
    Watkins, C
    Kallend, D
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 121 - 121
  • [7] GUIDELINE-BASED STATIN ALLOCATION TO DISTINGUISH BOTH CARDIOVASCULAR EVENTS AND CORONARY ARTERY CALCIFICATION IN THE COMMUNITY: A COMPARISON OF THE 2004 NCEP ATP III AND 2013 ACC/AHA CHOLESTEROL TREATMENT GUIDELINE
    Pursnani, Amit
    Massaro, Joseph
    D'Agostino, Ralph
    O'Donnell, Christopher
    Hoffmann, Udo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1355 - A1355
  • [8] LOW DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C) TARGET GOAL ACHIEVEMENT RATE ACCORDING TO PHYSICIANS' COMPLIANCE TO ESTABLISHED CLINICAL GUIDELINES FROM NATIONAL CHOLESTEROL EDUCATION PROGRAM-ADULT TREATMENT PANEL (NCEP-ATP) AND AMERICAN COLLEGE OF CARDIOLOGY/AMERICAN HEART ASSOCIATION (ACC/AHA): RESULTS FROM KOREA CRISTAR STUDY
    Chae, I
    Kim, B.
    Lee, J.
    Oh, J.
    Cho, B.
    Shin, E.
    Nah, D.
    Lee, S.
    Bae, J.
    Park, J.
    Hong, S. J.
    Hong, S. J.
    Cha, T.
    Cho, Y.
    Shin, W.
    Choi, S.
    Lee, K.
    Kim, S.
    Cha, J.
    Kim, Y.
    VALUE IN HEALTH, 2017, 20 (09) : A619 - A620
1